BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yamamoto T, Seino Y, Fukumoto H, Koh G, Yano H, Inagaki N, Yamada Y, Inoue K, Manabe T, Imura H. Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Commun. 1990;170:223-230. [PMID: 2372287 DOI: 10.1016/0006-291x(90)91263-r] [Cited by in Crossref: 325] [Cited by in F6Publishing: 102] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Valle-Mendiola A, Soto-Cruz I. Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes. Cancers (Basel) 2020;12:E124. [PMID: 31947710 DOI: 10.3390/cancers12010124] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
2 Pedersen MW, Holm S, Lund EL, Højgaard L, Kristjansen PE. Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro. Neoplasia 2001;3:80-7. [PMID: 11326319 DOI: 10.1038/sj.neo.7900133] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 3.0] [Reference Citation Analysis]
3 Tubbs JL, Pegg AE, Tainer JA. DNA binding, nucleotide flipping, and the helix-turn-helix motif in base repair by O6-alkylguanine-DNA alkyltransferase and its implications for cancer chemotherapy. DNA Repair (Amst) 2007;6:1100-15. [PMID: 17485252 DOI: 10.1016/j.dnarep.2007.03.011] [Cited by in Crossref: 120] [Cited by in F6Publishing: 109] [Article Influence: 8.6] [Reference Citation Analysis]
4 Carvalho KC, Cunha IW, Rocha RM, Ayala FR, Cajaíba MM, Begnami MD, Vilela RS, Paiva GR, Andrade RG, Soares FA. GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker. Clinics (Sao Paulo) 2011;66:965-72. [PMID: 21808860 DOI: 10.1590/s1807-59322011000600008] [Cited by in Crossref: 115] [Cited by in F6Publishing: 75] [Article Influence: 12.8] [Reference Citation Analysis]
5 Suwabe Y, Nakano R, Namba S, Yachiku N, Kuji M, Sugimura M, Kitanaka N, Kitanaka T, Konno T, Sugiya H, Nakayama T. Involvement of GLUT1 and GLUT3 in the growth of canine melanoma cells. PLoS One 2021;16:e0243859. [PMID: 33539362 DOI: 10.1371/journal.pone.0243859] [Reference Citation Analysis]
6 Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med 2013;34:121-38. [PMID: 23506862 DOI: 10.1016/j.mam.2012.07.001] [Reference Citation Analysis]
7 Volk T, Jähde E, Fortmeyer HP, Glüsenkamp KH, Rajewsky MF. pH in human tumour xenografts: effect of intravenous administration of glucose. Br J Cancer 1993;68:492-500. [PMID: 8353039 DOI: 10.1038/bjc.1993.375] [Cited by in Crossref: 111] [Cited by in F6Publishing: 103] [Article Influence: 4.0] [Reference Citation Analysis]
8 Revheim ME, Kristian A, Malinen E, Bruland ØS, Berner JM, Holm R, Joensuu H, Seierstad T. Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H. Acta Oncol 2013;52:776-82. [PMID: 23480638 DOI: 10.3109/0284186X.2013.770920] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Shimizu D, Kanda M, Kodera Y. Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer. World J Gastrointest Oncol 2018; 10(6): 124-136 [PMID: 29988904 DOI: 10.4251/wjgo.v10.i6.124] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
10 Zaal EA, Berkers CR. The Influence of Metabolism on Drug Response in Cancer. Front Oncol 2018;8:500. [PMID: 30456204 DOI: 10.3389/fonc.2018.00500] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 26.7] [Reference Citation Analysis]
11 León D, Uribe E, Zambrano A, Salas M. Implications of Resveratrol on Glucose Uptake and Metabolism. Molecules 2017;22:E398. [PMID: 28272357 DOI: 10.3390/molecules22030398] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
12 Sharma A, Boise LH, Shanmugam M. Cancer Metabolism and the Evasion of Apoptotic Cell Death. Cancers (Basel) 2019;11:E1144. [PMID: 31405035 DOI: 10.3390/cancers11081144] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
13 Reckzeh ES, Waldmann H. Small-Molecule Inhibition of Glucose Transporters GLUT-1-4. Chembiochem 2020;21:45-52. [PMID: 31553512 DOI: 10.1002/cbic.201900544] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
14 Frolova AI, Moley KH. Glucose transporters in the uterus: an analysis of tissue distribution and proposed physiological roles. Reproduction 2011;142:211-20. [PMID: 21642384 DOI: 10.1530/REP-11-0114] [Cited by in Crossref: 73] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
15 Wu S, Yin X, Fang X, Zheng J, Li L, Liu X, Chu L. c-MYC responds to glucose deprivation in a cell-type-dependent manner. Cell Death Discov 2015;1:15057. [PMID: 27551483 DOI: 10.1038/cddiscovery.2015.57] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
16 Aft RL, Zhang FW, Gius D. Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death. Br J Cancer. 2002;87:805-812. [PMID: 12232767 DOI: 10.1038/sj.bjc.6600547] [Cited by in Crossref: 163] [Cited by in F6Publishing: 156] [Article Influence: 8.6] [Reference Citation Analysis]
17 Chaise C, Itti E, Petegnief Y, Wirquin E, Copie-Bergman C, Farcet JP, Delfau-Larue MH, Meignan M, Talbot JN, Molinier-Frenkel V. [F-18]-Fluoro-2-deoxy-D: -glucose positron emission tomography as a tool for early detection of immunotherapy response in a murine B cell lymphoma model. Cancer Immunol Immunother 2007;56:1163-71. [PMID: 17171356 DOI: 10.1007/s00262-006-0265-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
18 Luo Y, Lu Z, Waaga-Gasser AM, Yang H, Liu J, Wu J, Lu J, Liu X, Zhang L. Modulation of Calcium Homeostasis May Be Associated with Susceptibility to Renal Cell Carcinoma in Diabetic Nephropathy Rats. Cancer Manag Res 2020;12:9679-89. [PMID: 33116827 DOI: 10.2147/CMAR.S268402] [Reference Citation Analysis]
19 Yang HJ, Xu WJ, Guan YH, Zhang HW, Ding WQ, Rong L, Qiu ZB, Zhong L. Expression of Glut-1 and HK-II in Pancreatic Cancer and Their Impact on Prognosis and FDG Accumulation. Transl Oncol 2016;9:583-91. [PMID: 27916293 DOI: 10.1016/j.tranon.2016.08.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
20 Yan Q, Lu Y, Zhou L, Chen J, Xu H, Cai M, Shi Y, Jiang J, Xiong W, Gao J, Wang H. Mechanistic insights into GLUT1 activation and clustering revealed by super-resolution imaging. Proc Natl Acad Sci U S A 2018;115:7033-8. [PMID: 29915035 DOI: 10.1073/pnas.1803859115] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
21 Nagarajan A, Dogra SK, Sun L, Gandotra N, Ho T, Cai G, Cline G, Kumar P, Cowles RA, Wajapeyee N. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport. Mol Cell 2017;67:685-701.e6. [PMID: 28803777 DOI: 10.1016/j.molcel.2017.07.014] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 14.0] [Reference Citation Analysis]
22 Colavolpe C, Chinot O, Metellus P, Mancini J, Barrie M, Bequet-Boucard C, Tabouret E, Mundler O, Figarella-Branger D, Guedj E. FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan. Neuro Oncol 2012;14:649-57. [PMID: 22379188 DOI: 10.1093/neuonc/nos012] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
23 Wagstaff P, Kang HY, Mylott D, Robbins PJ, White MK. Characterization of the avian GLUT1 glucose transporter: differential regulation of GLUT1 and GLUT3 in chicken embryo fibroblasts. Mol Biol Cell 1995;6:1575-89. [PMID: 8589457 DOI: 10.1091/mbc.6.11.1575] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
24 Amann T, Maegdefrau U, Hartmann A, Agaimy A, Marienhagen J, Weiss TS, Stoeltzing O, Warnecke C, Schölmerich J, Oefner PJ, Kreutz M, Bosserhoff AK, Hellerbrand C. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol 2009;174:1544-52. [PMID: 19286567 DOI: 10.2353/ajpath.2009.080596] [Cited by in Crossref: 179] [Cited by in F6Publishing: 184] [Article Influence: 14.9] [Reference Citation Analysis]
25 Levi J, Cheng Z, Gheysens O, Patel M, Chan CT, Wang Y, Namavari M, Gambhir SS. Fluorescent fructose derivatives for imaging breast cancer cells. Bioconjug Chem 2007;18:628-34. [PMID: 17444608 DOI: 10.1021/bc060184s] [Cited by in Crossref: 78] [Cited by in F6Publishing: 71] [Article Influence: 5.6] [Reference Citation Analysis]
26 Sivasudhan E, Blake N, Lu ZL, Meng J, Rong R. Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:642443. [PMID: 33869193 DOI: 10.3389/fcell.2021.642443] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Basturk O, Singh R, Kaygusuz E, Balci S, Dursun N, Culhaci N, Adsay NV. GLUT-1 expression in pancreatic neoplasia: implications in pathogenesis, diagnosis, and prognosis. Pancreas. 2011;40:187-192. [PMID: 21206329 DOI: 10.1097/mpa.0b013e318201c935] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
28 Mani S, Swargiary G, Singh KK. Natural Agents Targeting Mitochondria in Cancer. Int J Mol Sci 2020;21:E6992. [PMID: 32977472 DOI: 10.3390/ijms21196992] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
29 Ito A, Nasako H, Akizuki R, Takashina Y, Eguchi H, Matsunaga T, Yoshino Y, Endo S, Ikari A. Elevation of Chemosensitivity of Lung Adenocarcinoma A549 Spheroid Cells by Claudin-2 Knockdown through Activation of Glucose Transport and Inhibition of Nrf2 Signal. Int J Mol Sci 2021;22:6582. [PMID: 34205320 DOI: 10.3390/ijms22126582] [Reference Citation Analysis]
30 Nagamatsu S, Nakamichi Y, Inoue N, Inoue M, Nishino H, Sawa H. Rat C6 glioma cell growth is related to glucose transport and metabolism. Biochem J 1996;319 ( Pt 2):477-82. [PMID: 8912684 DOI: 10.1042/bj3190477] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.3] [Reference Citation Analysis]
31 Wang W, Xiao ZD, Li X, Aziz KE, Gan B, Johnson RL, Chen J. AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat Cell Biol. 2015;17:490-499. [PMID: 25751139 DOI: 10.1038/ncb3113] [Cited by in Crossref: 257] [Cited by in F6Publishing: 256] [Article Influence: 42.8] [Reference Citation Analysis]
32 Zhang Y, Wang J. Targeting uptake transporters for cancer imaging and treatment. Acta Pharm Sin B 2020;10:79-90. [PMID: 31993308 DOI: 10.1016/j.apsb.2019.12.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
33 De Matteis S, Ragusa A, Marisi G, De Domenico S, Casadei Gardini A, Bonafè M, Giudetti AM. Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities. Oxid Med Cell Longev 2018;2018:7512159. [PMID: 30524660 DOI: 10.1155/2018/7512159] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 16.3] [Reference Citation Analysis]
34 Charalampakis N, Xiao L, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Planjery V, Rogers JE, Matamoros A Jr, Sagebiel T, Das P, Lee JH, Bhutani MS, Weston B, Estrella JS, Badgwell BD, Ajani JA. Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively. Oncology 2015;89:305-10. [PMID: 26393501 DOI: 10.1159/000436972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
35 Weber J, Haberkorn U, Mier W. Cancer stratification by molecular imaging. Int J Mol Sci 2015;16:4918-46. [PMID: 25749472 DOI: 10.3390/ijms16034918] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
36 McDevitt TM, Tisdale MJ. Tumour-associated hypoglycaemia in a murine cachexia model. Br J Cancer 1992;66:815-20. [PMID: 1358167 DOI: 10.1038/bjc.1992.366] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.4] [Reference Citation Analysis]
37 Nałęcz KA. Amino Acid Transporter SLC6A14 (ATB0,+) - A Target in Combined Anti-cancer Therapy. Front Cell Dev Biol 2020;8:594464. [PMID: 33195271 DOI: 10.3389/fcell.2020.594464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
38 Mochiki E, Kuwano H, Katoh H, Asao T, Oriuchi N, Endo K. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg. 2004;28:247-253. [PMID: 14961197 DOI: 10.1007/s00268-003-7191-5] [Cited by in Crossref: 167] [Cited by in F6Publishing: 155] [Article Influence: 9.8] [Reference Citation Analysis]
39 Koutsioumpa M, Hatziapostolou M, Polytarchou C, Tolosa EJ, Almada LL, Mahurkar-Joshi S, Williams J, Tirado-Rodriguez AB, Huerta-Yepez S, Karavias D, Kourea H, Poultsides GA, Struhl K, Dawson DW, Donahue TR, Fernández-Zapico ME, Iliopoulos D. Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming. Gut 2019;68:1271-86. [PMID: 30337373 DOI: 10.1136/gutjnl-2017-315690] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
40 Zornhagen KW, Hansen AE, Oxboel J, Clemmensen AE, El Ali HH, Kristensen AT, Kjær A. Micro Regional Heterogeneity of 64Cu-ATSM and 18F-FDG Uptake in Canine Soft Tissue Sarcomas: Relation to Cell Proliferation, Hypoxia and Glycolysis. PLoS One 2015;10:e0141379. [PMID: 26501874 DOI: 10.1371/journal.pone.0141379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
41 Furuta E, Okuda H, Kobayashi A, Watabe K. Metabolic genes in cancer: their roles in tumor progression and clinical implications. Biochim Biophys Acta 2010;1805:141-52. [PMID: 20122995 DOI: 10.1016/j.bbcan.2010.01.005] [Cited by in Crossref: 47] [Cited by in F6Publishing: 129] [Article Influence: 4.3] [Reference Citation Analysis]
42 Mahraoui L, Rodolosse A, Barbat A, Dussaulx E, Zweibaum A, Rousset M, Brot-Laroche E. Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption. Biochem J 1994;298 Pt 3:629-33. [PMID: 8141777 DOI: 10.1042/bj2980629] [Cited by in Crossref: 112] [Cited by in F6Publishing: 114] [Article Influence: 4.1] [Reference Citation Analysis]
43 Rose DM, Delbeke D, Beauchamp RD, Chapman WC, Sandler MP, Sharp KW, Richards WO, Wright JK, Frexes ME, Pinson CW. 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg. 1999;229:729-737; discussion 737-738. [PMID: 10235532 DOI: 10.1097/00000658-199905000-00016] [Cited by in Crossref: 138] [Cited by in F6Publishing: 112] [Article Influence: 6.3] [Reference Citation Analysis]
44 Chan AK, Bruce JI, Siriwardena AK. Glucose metabolic phenotype of pancreatic cancer. World J Gastroenterol 2016; 22(12): 3471-3485 [PMID: 27022229 DOI: 10.3748/wjg.v22.i12.3471] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
45 Lee EE, Ma J, Sacharidou A, Mi W, Salato VK, Nguyen N, Jiang Y, Pascual JM, North PE, Shaul PW, Mettlen M, Wang RC. A Protein Kinase C Phosphorylation Motif in GLUT1 Affects Glucose Transport and is Mutated in GLUT1 Deficiency Syndrome. Mol Cell 2015;58:845-53. [PMID: 25982116 DOI: 10.1016/j.molcel.2015.04.015] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
46 Lis P, Dyląg M, Niedźwiecka K, Ko YH, Pedersen PL, Goffeau A, Ułaszewski S. The HK2 Dependent "Warburg Effect" and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate. Molecules 2016;21:E1730. [PMID: 27983708 DOI: 10.3390/molecules21121730] [Cited by in Crossref: 78] [Cited by in F6Publishing: 80] [Article Influence: 15.6] [Reference Citation Analysis]
47 Lei Y, Hu Q, Gu J. Expressions of Carbohydrate Response Element Binding Protein and Glucose Transporters in Liver Cancer and Clinical Significance. Pathol Oncol Res 2020;26:1331-40. [PMID: 31407220 DOI: 10.1007/s12253-019-00708-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
48 Hillier SM, Maresca KP, Femia FJ, Marquis JC, Foss CA, Nguyen N, Zimmerman CN, Barrett JA, Eckelman WC, Pomper MG, Joyal JL, Babich JW. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. Cancer Res 2009;69:6932-40. [PMID: 19706750 DOI: 10.1158/0008-5472.CAN-09-1682] [Cited by in Crossref: 205] [Cited by in F6Publishing: 102] [Article Influence: 17.1] [Reference Citation Analysis]
49 Fine EJ, Miller A, Quadros EV, Sequeira JM, Feinman RD. Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. Cancer Cell Int 2009;9:14. [PMID: 19480693 DOI: 10.1186/1475-2867-9-14] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
50 Chandra D, Selvanesan BC, Yuan Z, Libutti SK, Koba W, Beck A, Zhu K, Casadevall A, Dadachova E, Gravekamp C. 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect. Oncotarget 2017;8:20729-40. [PMID: 28186976 DOI: 10.18632/oncotarget.15117] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
51 Hicks RJ. Functional imaging techniques for evaluation of sarcomas. Cancer Imaging 2005;5:58-65. [PMID: 16154821 DOI: 10.1102/1470-7330.2005.0007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
52 Zheng Y, Chen Y, Jiang H, Zhang H, Wang H, Xu J, Yu Z. Circ_0058063 upregulates GLUT1 expression and promotes glucose-uptake in esophageal squamous-cell carcinomas. J Thorac Dis 2020;12:925-31. [PMID: 32274160 DOI: 10.21037/jtd.2019.12.57] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
53 Moriyama N, Kurimoto S, Kawabe K, Takata K, Hirano H. Immunohistochemical expression of glucose transporter-1 in human penile proliferative lesions. Histochem J 1997;29:273-8. [PMID: 9184841 DOI: 10.1023/a:1026466229242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
54 Kurata T, Oguri T, Isobe T, Ishioka S, Yamakido M. Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases. Jpn J Cancer Res. 1999;90:1238-1243. [PMID: 10622535 DOI: 10.1111/j.1349-7006.1999.tb00702.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 2.9] [Reference Citation Analysis]
55 Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med 2013;34:121-38. [PMID: 23506862 DOI: 10.1016/j.mam.2012.07.001] [Reference Citation Analysis]
56 Gerhart DZ, Broderius MA, Borson ND, Drewes LR. Neurons and microvessels express the brain glucose transporter protein GLUT3. Proc Natl Acad Sci U S A 1992;89:733-7. [PMID: 1731347 DOI: 10.1073/pnas.89.2.733] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 2.0] [Reference Citation Analysis]
57 Wang H, Ma Z, Cheng X, Tuo B, Liu X, Li T. Physiological and Pathophysiological Roles of Ion Transporter-Mediated Metabolism in the Thyroid Gland and in Thyroid Cancer. Onco Targets Ther 2020;13:12427-41. [PMID: 33299328 DOI: 10.2147/OTT.S280797] [Reference Citation Analysis]
58 Důra M, Němejcová K, Jakša R, Bártů M, Kodet O, Tichá I, Michálková R, Dundr P. Expression of Glut-1 in Malignant Melanoma and Melanocytic Nevi: an Immunohistochemical Study of 400 Cases. Pathol Oncol Res 2019;25:361-8. [PMID: 29128957 DOI: 10.1007/s12253-017-0363-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
59 Chang SH, Chung YS, Hwang SK, Kwon JT, Minai-Tehrani A, Kim S, Park SB, Kim YS, Cho MH. Lentiviral vector-mediated shRNA against AIMP2-DX2 suppresses lung cancer cell growth through blocking glucose uptake. Mol Cells 2012;33:553-62. [PMID: 22562359 DOI: 10.1007/s10059-012-2269-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
60 Westerterp M, Sloof GW, Hoekstra OS, Ten Kate FJ, Meijer GA, Reitsma JB, Boellaard R, van Lanschot JJ, Molthoff CF. 18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome. J Cancer Res Clin Oncol. 2008;134:227-236. [PMID: 17653575 DOI: 10.1007/s00432-007-0275-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
61 Champ CE, Palmer JD, Volek JS, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Shi W. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. J Neurooncol 2014;117:125-31. [PMID: 24442482 DOI: 10.1007/s11060-014-1362-0] [Cited by in Crossref: 116] [Cited by in F6Publishing: 103] [Article Influence: 16.6] [Reference Citation Analysis]
62 Nagarajan A, Malvi P, Wajapeyee N. Oncogene-directed alterations in cancer cell metabolism. Trends Cancer 2016;2:365-77. [PMID: 27822561 DOI: 10.1016/j.trecan.2016.06.002] [Cited by in Crossref: 87] [Cited by in F6Publishing: 75] [Article Influence: 17.4] [Reference Citation Analysis]
63 Veal CD, Reekie KE, Lorentzen JC, Gregersen PK, Padyukov L, Brookes AJ. A 129-kb deletion on chromosome 12 confers substantial protection against rheumatoid arthritis, implicating the gene SLC2A3. Hum Mutat 2014;35:248-56. [PMID: 24178905 DOI: 10.1002/humu.22471] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
64 Daskalow K, Pfander D, Weichert W, Rohwer N, Thelen A, Neuhaus P, Jonas S, Wiedenmann B, Benckert C, Cramer T. Distinct temporospatial expression patterns of glycolysis-related proteins in human hepatocellular carcinoma. Histochem Cell Biol. 2009;132:21-31. [PMID: 19350262 DOI: 10.1007/s00418-009-0590-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
65 Kannan S, Begoyan VV, Fedie JR, Xia S, Weseliński ŁJ, Tanasova M, Rao S. Metabolism-Driven High-Throughput Cancer Identification with GLUT5-Specific Molecular Probes. Biosensors (Basel) 2018;8:E39. [PMID: 29642606 DOI: 10.3390/bios8020039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
66 Lambert DW, Wood IS, Ellis A, Shirazi-Beechey SP. Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy. Br J Cancer. 2002;86:1262-1269. [PMID: 11953883 DOI: 10.1038/sj.bjc.6600264] [Cited by in Crossref: 100] [Cited by in F6Publishing: 90] [Article Influence: 5.3] [Reference Citation Analysis]
67 Zamora-León SP, Golde DW, Concha II, Rivas CI, Delgado-López F, Baselga J, Nualart F, Vera JC. Expression of the fructose transporter GLUT5 in human breast cancer. Proc Natl Acad Sci U S A 1996;93:1847-52. [PMID: 8700847 DOI: 10.1073/pnas.93.5.1847] [Cited by in Crossref: 127] [Cited by in F6Publishing: 121] [Article Influence: 5.1] [Reference Citation Analysis]
68 Ulanovskaya OA, Cui J, Kron SJ, Kozmin SA. A pairwise chemical genetic screen identifies new inhibitors of glucose transport. Chem Biol 2011;18:222-30. [PMID: 21338919 DOI: 10.1016/j.chembiol.2010.12.015] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
69 Thirabanjasak D, Basturk O, Altinel D, Cheng JD, Adsay NV. Is serous cystadenoma of the pancreas a model of clear-cell-associated angiogenesis and tumorigenesis? Pancreatology 2009;9:182-8. [PMID: 19077470 DOI: 10.1159/000178890] [Cited by in Crossref: 40] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
70 Poliaková M, Aebersold DM, Zimmer Y, Medová M. The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer. Mol Cancer 2018;17:27. [PMID: 29455660 DOI: 10.1186/s12943-018-0798-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
71 Vander Heiden MG. Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov. 2011;10:671-684. [PMID: 21878982 DOI: 10.1038/nrd3504] [Cited by in Crossref: 939] [Cited by in F6Publishing: 867] [Article Influence: 93.9] [Reference Citation Analysis]
72 Zambrano A, Molt M, Uribe E, Salas M. Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy. Int J Mol Sci 2019;20:E3374. [PMID: 31324056 DOI: 10.3390/ijms20133374] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 18.0] [Reference Citation Analysis]
73 Lee SH, Park JS, Kim H, Kim D, Lee SH, Ham WS, Han WK, Choi YD, Yun M. Glycolysis on F-18 FDG PET/CT Is Superior to Amino Acid Metabolism on C-11 Methionine PET/CT in Identifying Advanced Renal Cell Carcinoma at Staging. Cancers (Basel) 2021;13:2381. [PMID: 34069168 DOI: 10.3390/cancers13102381] [Reference Citation Analysis]
74 Chen LY, Phelix CF. Extracellular gating of glucose transport through GLUT 1. Biochem Biophys Res Commun 2019;511:573-8. [PMID: 30824189 DOI: 10.1016/j.bbrc.2019.02.067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
75 Prabhulkar S, Matthews J, Rawal S, Awdeh RM. Molecular histopathology using gold nanorods and optical coherence tomography. Invest Ophthalmol Vis Sci 2013;54:1192-200. [PMID: 23307958 DOI: 10.1167/iovs.12-10794] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
76 Takanaga H, Chaudhuri B, Frommer WB. GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. Biochim Biophys Acta 2008;1778:1091-9. [PMID: 18177733 DOI: 10.1016/j.bbamem.2007.11.015] [Cited by in Crossref: 195] [Cited by in F6Publishing: 175] [Article Influence: 13.9] [Reference Citation Analysis]
77 Godoy A, Salazar K, Figueroa C, Smith GJ, de Los Angeles Garcia M, Nualart FJ. Nutritional channels in breast cancer. J Cell Mol Med 2009;13:3973-84. [PMID: 19602043 DOI: 10.1111/j.1582-4934.2008.00544.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
78 Ishikawa N, Oguri T, Isobe T, Fujitaka K, Kohno N. SGLT gene expression in primary lung cancers and their metastatic lesions. Jpn J Cancer Res. 2001;92:874-879. [PMID: 11509120 DOI: 10.1111/j.1349-7006.2001.tb01175.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 3.0] [Reference Citation Analysis]
79 Kumari S, Khan S, Gupta SC, Kashyap VK, Yallapu MM, Chauhan SC, Jaggi M. MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer. Oncogenesis 2018;7:19. [PMID: 29467405 DOI: 10.1038/s41389-018-0031-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
80 Sieger S, Jiang S, Schönsiegel F, Eskerski H, Kübler W, Altmann A, Haberkorn U. Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3). Eur J Nucl Med Mol Imaging 2003;30:748-56. [PMID: 12541134 DOI: 10.1007/s00259-002-1099-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
81 George Thompson AM, Iancu CV, Nguyen TT, Kim D, Choe JY. Inhibition of human GLUT1 and GLUT5 by plant carbohydrate products; insights into transport specificity. Sci Rep 2015;5:12804. [PMID: 26306809 DOI: 10.1038/srep12804] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
82 Sebastián C, Zwaans BM, Silberman DM, Gymrek M, Goren A, Zhong L, Ram O, Truelove J, Guimaraes AR, Toiber D, Cosentino C, Greenson JK, MacDonald AI, McGlynn L, Maxwell F, Edwards J, Giacosa S, Guccione E, Weissleder R, Bernstein BE, Regev A, Shiels PG, Lombard DB, Mostoslavsky R. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 2012;151:1185-99. [PMID: 23217706 DOI: 10.1016/j.cell.2012.10.047] [Cited by in Crossref: 426] [Cited by in F6Publishing: 393] [Article Influence: 53.3] [Reference Citation Analysis]
83 Nyflot MJ, Harari PM, Yip S, Perlman SB, Jeraj R. Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx. Radiother Oncol. 2012;105:36-40. [PMID: 23068711 DOI: 10.1016/j.radonc.2012.09.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
84 Reis H, Tschirdewahn S, Szarvas T, Rübben H, Schmid KW, Grabellus F. Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladder. Oncol Lett 2011;2:1149-53. [PMID: 22848280 DOI: 10.3892/ol.2011.394] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
85 Pezzuto A, D'Ascanio M, Ricci A, Pagliuca A, Carico E. Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review. Thorac Cancer 2020;11:3060-70. [PMID: 32945604 DOI: 10.1111/1759-7714.13651] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
86 Demény MA, Virág L. The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks. Cancers (Basel) 2021;13:2042. [PMID: 33922595 DOI: 10.3390/cancers13092042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
87 Ceballos J, Schwalfenberg M, Karageorgis G, Reckzeh ES, Sievers S, Ostermann C, Pahl A, Sellstedt M, Nowacki J, Carnero Corrales MA, Wilke J, Laraia L, Tschapalda K, Metz M, Sehr DA, Brand S, Winklhofer K, Janning P, Ziegler S, Waldmann H. Synthesis of Indomorphan Pseudo-Natural Product Inhibitors of Glucose Transporters GLUT-1 and -3. Angew Chem Int Ed Engl 2019;58:17016-25. [PMID: 31469221 DOI: 10.1002/anie.201909518] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
88 Nourani A, Wesolowski-Louvel M, Delaveau T, Jacq C, Delahodde A. Multiple-drug-resistance phenomenon in the yeast Saccharomyces cerevisiae: involvement of two hexose transporters. Mol Cell Biol 1997;17:5453-60. [PMID: 9271421 DOI: 10.1128/MCB.17.9.5453] [Cited by in Crossref: 81] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
89 Anderle P, Rakhmanova V, Woodford K, Zerangue N, Sadée W. Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines. Pharm Res 2003;20:3-15. [PMID: 12608530 DOI: 10.1023/a:1022282221530] [Cited by in Crossref: 41] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
90 Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med. 2013;34:121-138. [PMID: 23506862 DOI: 10.1016/j.mam.2012.07.001] [Cited by in Crossref: 583] [Cited by in F6Publishing: 518] [Article Influence: 72.9] [Reference Citation Analysis]
91 Ebert BL, Gleadle JM, O'Rourke JF, Bartlett SM, Poulton J, Ratcliffe PJ. Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin. Biochem J 1996;313 ( Pt 3):809-14. [PMID: 8611159 DOI: 10.1042/bj3130809] [Cited by in Crossref: 109] [Cited by in F6Publishing: 103] [Article Influence: 4.4] [Reference Citation Analysis]
92 Kaina B, Margison GP, Christmann M. Targeting O⁶-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy. Cell Mol Life Sci 2010;67:3663-81. [PMID: 20717836 DOI: 10.1007/s00018-010-0491-7] [Cited by in Crossref: 95] [Cited by in F6Publishing: 84] [Article Influence: 8.6] [Reference Citation Analysis]
93 Bonomi M, De Filippis C, Lopci E, Gianoncelli L, Rizzardi G, Cerchiaro E, Bortolotti L, Zanello A, Ceresoli GL. Clinical staging of malignant pleural mesothelioma: current perspectives. Lung Cancer (Auckl) 2017;8:127-39. [PMID: 28860886 DOI: 10.2147/LCTT.S102113] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
94 Hong R, Lim SC. 18F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma. World J Gastroenterol 2012; 18(2): 168-174 [PMID: 22253523 DOI: 10.3748/wjg.v18.i2.168] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
95 Estilo CL, O-charoenrat P, Talbot S, Socci ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y, Boyle JO, Kraus DH, Patel S, Shaha AR, Wong RJ, Huryn JM, Shah JP, Singh B. Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 2009;9:11. [PMID: 19138406 DOI: 10.1186/1471-2407-9-11] [Cited by in Crossref: 131] [Cited by in F6Publishing: 131] [Article Influence: 10.9] [Reference Citation Analysis]
96 Colavolpe C, Metellus P, Mancini J, Barrie M, Béquet-Boucard C, Figarella-Branger D, Mundler O, Chinot O, Guedj E. Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas. J Neurooncol 2012;107:527-35. [PMID: 22169956 DOI: 10.1007/s11060-011-0771-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
97 Harris DS, Slot JW, Geuze HJ, James DE. Polarized distribution of glucose transporter isoforms in Caco-2 cells. Proc Natl Acad Sci U S A 1992;89:7556-60. [PMID: 1502167 DOI: 10.1073/pnas.89.16.7556] [Cited by in Crossref: 73] [Cited by in F6Publishing: 80] [Article Influence: 2.5] [Reference Citation Analysis]
98 Nagamatsu S, Sawa H, Inoue N, Nakamichi Y, Takeshima H, Hoshino T. Gene expression of GLUT3 glucose transporter regulated by glucose in vivo in mouse brain and in vitro in neuronal cell cultures from rat embryos. Biochem J 1994;300 ( Pt 1):125-31. [PMID: 8198523 DOI: 10.1042/bj3000125] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 1.5] [Reference Citation Analysis]
99 Ghezzi C, Wong A, Chen BY, Ribalet B, Damoiseaux R, Clark PM. A high-throughput screen identifies that CDK7 activates glucose consumption in lung cancer cells. Nat Commun 2019;10:5444. [PMID: 31784510 DOI: 10.1038/s41467-019-13334-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
100 Suh S, Kim YH, Goh TS, Jeong DC, Lee CS, Jang JY, Cha W, Han ME, Kim SJ, Kim IJ, Pak K. mRNA Expression of SLC5A5 and SLC2A Family Genes in Papillary Thyroid Cancer: An Analysis of The Cancer Genome Atlas. Yonsei Med J 2018;59:746-53. [PMID: 29978611 DOI: 10.3349/ymj.2018.59.6.746] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
101 Al-Azzam N. Sirtuin 6 and metabolic genes interplay in Warburg effect in cancers. J Clin Biochem Nutr 2020;66:169-75. [PMID: 32523242 DOI: 10.3164/jcbn.19-110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
102 Juraszek B, Nałęcz KA. SLC22A5 (OCTN2) Carnitine Transporter-Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer. Molecules 2019;25:E14. [PMID: 31861504 DOI: 10.3390/molecules25010014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]